Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07045051 · ClinicalTrials.gov registry record · NA
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
A NA study of Healthy Participants, sponsored by Ball State University.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07045051: Recruiting NA study of Healthy Participants, sponsored by Ball State University.
NCT07045051 is a NA study of Healthy Participants that is actively recruiting participants, run by Ball State University. The registered enrollment target is 24 participants, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07045051, a NA study of Healthy Participants, is actively recruiting participants, sponsored by Ball State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in blood sugar may also negatively impact vascular health. Previous research suggests that mango consumed in small quantities has blood sugar-lowering properties, but the evidence of this within larger, more realistic meals is limited. The investigators want to understand if replacing table sugar (sucrose) with sugar from fresh mango (which also contains fiber and plant bioactives) will lead to more favorable blood sugar, insulin, and vascular responses after eating breakfast meals. The investigators will compare the postprandial glycemic, insulinemic, and vascular response to low and high glycemic meals sweetened with either fresh mango or sucrose.
Primary Outcome
The investigators will measure glucose at baseline and .5-, 1-, 2-, and 3-hours after each meal. These measurements will take place immediately and a complete dataset will be compiled upon study completion.
Conditions Studied
Interventions
- OTHER Low-Glycemic Breakfast Containing Oats and Mango
- OTHER High-Glycemic Breakfast Containing Cereal and Mango
- OTHER Low-Glycemic Breakfast Containing Oats and Table Sugar
- OTHER High-Glycemic Breakfast Containing Cereal and Table Sugar
Study Locations (1)
Indiana
- Health Professions Building, Ball State University - Muncie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-03-26 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT07045051 shows while recruiting
NCT07045051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 4 interventions - of which Low-Glycemic Breakfast Containing Oats and Mango is the first listed.
NCT07045051 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07045051 about?
NCT07045051 is a clinical study titled "Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.". Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in blood sugar may also negatively impact vascular health. Previous research suggests that mango consumed in small quantities has blood sugar-lowe...
What is the current status of trial NCT07045051?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-03-26. Estimated completion is 2026-12-01.
What conditions does trial NCT07045051 study?
This clinical trial studies the following conditions: Healthy Participants.
What interventions are being tested in trial NCT07045051?
The interventions under investigation include: Low-Glycemic Breakfast Containing Oats and Mango (OTHER), High-Glycemic Breakfast Containing Cereal and Mango (OTHER), Low-Glycemic Breakfast Containing Oats and Table Sugar (OTHER), High-Glycemic Breakfast Containing Cereal and Table Sugar (OTHER).
Who is sponsoring clinical trial NCT07045051?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07045051 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07045051's enrollment target sits among peer trials
24 80th of 119 higher than 30 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
-
Royal Ancient Oats™ Study
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI